Multiple Myeloma is rated by the U.S. Department of Veterans Affairs under DC 7703 of 38 CFR § 4.117, DC 7703 across 5 severity tiers (0% / 10% / 30% / 60% / 100%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.
Cancer of plasma cells in the bone marrow. Causes bone pain, fractures, kidney damage, anemia, and recurrent infections. Treated with chemotherapy, stem cell transplant, and targeted therapy.
Rating criteria reference 38 C.F.R. Part 4 (Schedule for Rating Disabilities). This entry has not yet undergone editorial review against the live regulation text — consult the authoritative source directly before relying on the criteria shown.